Clinical Trials Browser

Phase 2 × OTHER × thymoquinone × Clear all

NCT03208790 2021-04-20

Clinical and Immunohisochemical Evaluation of Chemopreventive Effect of Thymoquinone on Oral Potentially Malignant Lesions.

Phase 2 Completed

Premalignant Lesion